Marvell's Google Warrant Carries a $120 Billion Promise — and a 7% Dilution Question

Google's $12.2B warrant in Marvell is revenue-linked, not time-based, signaling deep AI chip partnership. Analysts split on upside vs. dilution.

The mechanics of the deal are deceptively simple on paper: Alphabet receives the right to buy up to 58.97 million Marvell Technology shares at $206.58 apiece, a package worth roughly $12.2 billion if fully exercised. But the structure beneath that headline figure is what makes the agreement genuinely unusual — and why the market's initial reaction has been so telling.

Google's warrant vests in tranches tied directly to revenue, not time. Just 1.36 million shares unlock in the first year; the remaining 57.6 million become exercisable in 240 installments of $500 million each in custom-product sales, stretching all the way to fiscal 2033. Stifel estimates the cumulative revenue potential at up to $120 billion over that window, a staggering figure for a company whose trailing annual sales stand at $8.20 billion.

A vote of confidence with strings attached

What makes this arrangement notable is what it signals about the buyer-supplier relationship. Google isn't simply purchasing chips — it's tying its equity upside to Marvell's ability to deliver on custom silicon for its TPU ecosystem, spanning AI inference accelerators, memory controllers, and network interface components. The warrant functions as an incentive mechanism as much as a financial instrument, aligning both companies' interests around execution rather than just order volume.

The competitive ripples were immediate. Broadcom, previously Google's exclusive TPU supplier, saw its shares slide roughly 5% on the news — a stark illustration of how tightly hyperscaler decisions now bind the fortunes of custom-silicon vendors. Market observers also flagged pressure on AMD and MediaTek as Google's supplier base visibly broadens.

Analyst scores are split across the board

Wall Street's response has been characteristically mixed. UBS's Timothy Arcuri reaffirmed a buy rating while lifting his price target from $300 to $310, though he cautioned that meaningful revenue from the deal isn't expected until after 2028 — meaning today's enthusiasm bakes in considerable forward credit. Morningstar struck a similarly constructive tone, raising its target to $270.

Others are more measured. TD Cowen moved its target from $200 to $225 with a Hold rating, citing Marvell's leadership in optical DSP solutions for AI data centers. Goldman Sachs nudged its target from $180 to $195, maintaining a neutral stance while acknowledging the company's strong position in custom silicon. Morgan Stanley, at $195 with an Equal Weight rating, pointed instead to a potential additional Google chip codenamed "Frozen v2" as a possible source of further upside.

The dilution question lingers beneath the optimism. If Google exercises the full warrant, existing shareholders face up to 7% dilution — a real cost that some analysts argue the market is glossing over in the excitement.

A stock caught between momentum and gravity

The market's initial response was positive but restrained. Marvell shares climbed 4.1% on the announcement, leaving the stock 3.3% above its 50-day moving average — evidence that short-term momentum remains intact even as the shares sit roughly 31% below their 52-week high of $290.35, reached in early June. Year-to-date, the stock is still up 176%, propelled by relentless demand for AI infrastructure.

That tension — structural opportunity against immediate dilution, long-term promise against near-term valuation — defines Marvell's current phase. Alphabet just completed an $84.75 billion equity raise, the largest in U.S. history, partly to fund AI infrastructure. Nvidia is simultaneously pursuing $500 billion in financing for GPU capacity expansion. The capital hunger across hyperscalers shows no signs of abating, and Marvell's heavy reliance on that spending — over three-quarters of revenue now comes from hyperscalers — cuts both ways.

India expansion and the August 27 reckoning

Separately, Marvell announced plans to invest $250 million over the next three years to expand its R&D operations in Bangalore and Hyderabad, with plans to double the workforce there and make India its second-largest development hub.

The immediate test comes on August 27, when Marvell reports second-quarter fiscal 2027 results. Consensus calls for revenue of $2.71 billion, up 35% year over year. Investors will be listening for early signals on how the Google partnership is tracking toward its vesting thresholds. An investor day follows on October 6.

A potential regulatory tailwind could also be forming: reports suggest the FCC is considering a ban on new optical transceivers manufactured in China, which would likely shift demand toward non-Chinese suppliers like Marvell.

The warrant deal has raised expectations considerably. Whether the underlying business can meet them is a question that won't be answered in a single trading session — but next week's earnings will offer the first real glimpse.